Skip to main content

Advertisement

SpringerLink
Log in

Hormonal Therapy for Epilepsy

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

In 2011, there are greater than 20 antiepileptic medications available. These medications work by modulating neuronal excitability. Reproductive hormones have been found to have a role in the pathogenesis and treatment of seizures by also altering neuronal excitability, especially in women with catamenial epilepsy. The female reproductive hormones have in general opposing effects on neuronal excitability; estrogens generally impart a proconvulsant neurophysiologic tone, whereas the progestogens have anticonvulsant effects. It follows then that fluctuations in the levels of serum progesterone and estrogen throughout a normal reproductive cycle bring about an increased or decreased risk of seizure occurrence based upon the serum estradiol/progesterone ratio. Therefore, using progesterone, its metabolite allopregnanolone, or other hormonal therapies have been explored in the treatment of patients with epilepsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. French JA. Treatment with antiepileptic drugs, new and old. Continuum Lifelong Learning Neurol. 2007;13:71–80.

    Google Scholar 

  2. Morrell MJ. Hormones and epilepsy through the lifetime. Epilepsia. 1992;33 Suppl 4:S49–61.

    Article  PubMed  Google Scholar 

  3. •• Herzog AG. Catamenial epilepsy: definition, prevalence, pathophysiology and treatment. Seizure 2008; 17:151–9. This article provides a detailed definition of catamenial epilepsy and is a current evaluation of the pathophysiology and treatment, both hormonal and nonhormonal, of this disorder.

    Article  PubMed  Google Scholar 

  4. Bäckström T, Zetterlund B, Blom S, et al. Effects of intravenous progesterone during the menstrual cycle. Acta Neurol Scand. 1976;54:321–47.

    Article  PubMed  Google Scholar 

  5. Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology. 2001;57:2133–5.

    PubMed  CAS  Google Scholar 

  6. Abbasi F, Krumholz A, Kittner SJ, et al. Effects of menopause on seizures in women with epilepsy. Epilepsia. 1999;40:205–10.

    Article  PubMed  CAS  Google Scholar 

  7. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia. 1997;38:1082–8.

    Article  PubMed  CAS  Google Scholar 

  8. Sherman BM, Korenman SG. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab. 1974;39:145–9.

    Article  PubMed  CAS  Google Scholar 

  9. Morrell MJ, Giudice L, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol. 2002;52:704–7.

    Article  PubMed  Google Scholar 

  10. Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia. 1995;36:355–9.

    Article  PubMed  CAS  Google Scholar 

  11. • Velíšek L, Velíšková J. New avenue of research: antiepileptic drug and estradiol neuroprotection in epilepsy. Recent Pat CNS Drug Discov 2008; 3:128–37. This article reviews both the proconvulsant and neuroprotective features of estrogens when taking into account the dosage paradigm, timing, sex of the subjects, and their gonadal hormone status. It also reviews several studies that have demonstrated that estradiol has potency to protect neurons from seizure-induced brain damage.

    Article  PubMed  Google Scholar 

  12. Wooley DE, Timiras PS. The gonad-brain relationship: effects of female sex hormones and electroshock convulsions in the rat. Endocrinology. 1962;70:196–209.

    Article  Google Scholar 

  13. Woolley CS. Estradiol facilitates kainic acid-induced, but not flurothyl-induced behavioral seizure activity in adult female rats. Epilepsia. 2000;41:510–5.

    Article  PubMed  CAS  Google Scholar 

  14. Wallis CJ, Luttge WG. Influence of estrogen and progesterone on glutamic acid decarboxylase activity in discrete regions of rate brain. J Neurochem. 1980;34:609–13.

    Article  PubMed  CAS  Google Scholar 

  15. Weiland NG. Estradiol selectively regulates agonist binding sites on the N-mehtyl-D-aspartate receptor complex in the CA-1 region of the hippocampus. Endocrinology. 1992;131:662–8.

    Article  PubMed  CAS  Google Scholar 

  16. • Reddy DS. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res 2009; 85: 1–30. This is a detailed review on the pathophysiology of catamenial epilepsy and in-depth analysis of how neurosteroids could be used in the treatment of women with this disorder.

    Article  PubMed  CAS  Google Scholar 

  17. •• Herzog AG. Hormonal therapies: progesterone. Neurotherapeutics 2009; 6:383–91. This article reviews the pathophysiology and treatment of catamenial epilepsy and provides an up-to-date review of using progesterone therapy in women with catamenial epilepsy.

    Article  PubMed  CAS  Google Scholar 

  18. • Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009; 6:392–401. This article provides detail on the pathophysiology of catamenial epilepsy and evaluates how synthetic analogues of progesterone metabolites may work on GABAA channels to therapeutically reduce seizures.

    Article  PubMed  CAS  Google Scholar 

  19. El-Khayat HA, Soliman NA, Tomoum HY, et al. Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy. Epilepsia. 2008;49:1619–26.

    Article  PubMed  Google Scholar 

  20. Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol. 2003;53:390–1.

    Article  PubMed  CAS  Google Scholar 

  21. Herzog AG. Intermittent progesterone therapy of partial complex seizures in women with menstrual disorders. Neurology. 1986;36:1607–10.

    PubMed  CAS  Google Scholar 

  22. Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology. 1995;45:1660–2.

    PubMed  CAS  Google Scholar 

  23. Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology. 1999;52:1917–8.

    PubMed  CAS  Google Scholar 

  24. Mattson RH, Cramer JA, Caldwell BV, et al. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology. 1984;34:1255–8.

    PubMed  CAS  Google Scholar 

  25. Bauer J, Wildt L, Flugel D, et al. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol. 1992;239:284–6.

    Article  PubMed  CAS  Google Scholar 

  26. Haider Y, Barnett DB. Catamenial epilepsy and goserelin. Lancet. 1991;338:1530.

    Article  PubMed  CAS  Google Scholar 

  27. Herzog AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology. 1988;38:432–4.

    PubMed  CAS  Google Scholar 

  28. Laxer K, Blum D, Abou-Khalil BW, et al. Assessment of ganaxolone’s anticonvulsant activity using a randomized, double-blind, presurgical trial design. Epilepsia. 2000;41:1187–94.

    Article  PubMed  CAS  Google Scholar 

  29. Kerrigan JF, Shields WD, Nelson TY, et al. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res. 2000;42:133–9.

    Article  PubMed  CAS  Google Scholar 

  30. Pieribone VA, Tsai J, Soufflet C, et al. Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy. Epilepsia. 2007;48:1870–4.

    Article  PubMed  CAS  Google Scholar 

  31. Nohria V, Giller E. Ganaxolone. Neurotherapeutics. 2007;4:102–5.

    Article  PubMed  CAS  Google Scholar 

  32. Reddy DS. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol. Neuroscience. 2004;129:195–207.

    Article  PubMed  CAS  Google Scholar 

  33. Reddy DS. Anticonvulsant activity of the testosterone-derived neurosteroid 3α-androstanediol. Neuroreport. 2004;15:515–8.

    Article  PubMed  CAS  Google Scholar 

  34. Kaminski RM, Marini H, Kim W, et al. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia. 2005;46:819–27.

    Article  PubMed  CAS  Google Scholar 

  35. Herzog AG, Klein P, Jacobs AR. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology. 1998;50:782–4.

    PubMed  CAS  Google Scholar 

  36. Herzog AG, Farina E, Drislane F, et al. A comparison of anastrozole and testosterone versus placebo and testosterone for treatment of sexual dysfunction in men with epilepsy and hypogonadism. Epilepsy Behav. 2010;17:264–71.

    Article  PubMed  Google Scholar 

  37. Harden CL, MackLusky NJ. Aromatase inhibitors as add-on treatment for men with epilepsy. Expert Rev Neurother. 2005;5:123–7.

    Article  PubMed  CAS  Google Scholar 

  38. Harden CL, Pulver MC, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia. 1999;40:1402–7.

    Article  PubMed  CAS  Google Scholar 

  39. Harden CL, Herzog AG, Nikolov BG, et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsy. 2006;47:1447–51.

    Article  CAS  Google Scholar 

  40. • Chelbowski RT, Anderson GL, Gass M, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010; 304:1684–92. This article illustrates a greater breast cancer incidence and mortality in women taking estrogen plus progestin HRT.

    Article  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Neurology, Hofstra North Shore-LIJ School of Medicine, Division of Epilepsy and Electroencephalography, Harvey Cushing Institutes of Neuroscience, North Shore-Long Island Jewish Health System, 270-05 76th Avenue, New Hyde Park, NY, 11040, USA

    Scott J. Stevens & Cynthia L. Harden

Authors
  1. Scott J. Stevens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cynthia L. Harden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott J. Stevens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stevens, S.J., Harden, C.L. Hormonal Therapy for Epilepsy. Curr Neurol Neurosci Rep 11, 435–442 (2011). https://doi.org/10.1007/s11910-011-0196-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-011-0196-9

Keywords

Search

Navigation